VETONE

Manufacturer
MWI | Sypharma Pty Ltd | New Zealand Salt Company Limited
Effective date
2018-08-30
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:52:22

Label at a glance#

ProductVETONE
Active ingredientSODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE
Label structure3 sections

Label contents#

Full prescribing information#

SPL PATIENT PACKAGE INSERT SECTION

STERILE NONPYROGENIC SOLUTION

For Animal Use Only

DESCRIPTION

DESCRIPTION SECTION

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection, Type 1, USP) is a sterile, non–pyrogenic

isotonic solution intended for fluid and electrolyte replenishment in single dose containers. May

be administered intravenously using aseptic technique. It contains no antimicrobial agents·

Discard any unused portion. The pH is adjusted with Sodium Hydroxide. Composition,

osmolarity, pH and ionic concentration and caloric content are shown in Tabe 1·

image descriptionimage description
Osmolarity (mOsmol⁄L) (calc):294 mOsmol per litre

pH: 7·4 (limit 6.5 to 8.0)

The container is free of PVC and phthalates. The container meets the requirements of

USP and is registered with US FDA·

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

A multiple electrolyte intravenous solution is intended to restore the electrolyte balance and

water for hydration· It is capable of inducing diuresis depending on the clinical condition of

the patient and produces a metabolic alkalinizing effect. Acetate and gluconate ions are

metabolized ultimately to carbon dioxide and water‚ which requires the consumption of

hydrogen cations·

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) is indicated as a source

of water and electrolytes for all species· It is also used as an alkalinizing agent.

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) is compatible with blood

or blood components. It may be administered prior to or following the infusion of blood

through the same administration set (i·e., as a priming solution), added to or infused

concurrently with blood components, or used as a diluent in the transfusion of packed

erythrocytes·

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

None known

WARNINGS

WARNINGS SECTION

The introduction of additives to any solution, regardless of type of container, requires special

attention to ensure that no incompatibilities result. While some incompatibilities are readily

absorbed, one must be aware that subtle physical, chemical and pharmacological incompatibilities

can occur. The medical literature, the package insert and other available sources of information

should be reviewed for thorough understanding of possible incompatibilities·

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) should be used with

great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and

in clinical states in which there exists edema and sodium retention.

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) should be used with

great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions

in which potassium retention is present.

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) should be used with

great care in patients with metabolic or respiratory alkalosis. The administration of acetate

or gluconate ions should be done with great care in those conditions in which there is an

increased level or an impaired utilization of these ions, such as severe hepatic insufficiency·

The intravenous administration of VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚

Type 1‚ USP) can cause fluid and⁄or solute overloading resulting in dilution of serum

electrolyte concentrations, over-hydration, congested states, or pulmonary edema. The

risk of dilutional states is inversely proportional to the electrolyte concentrations of the

injection. The risk of solute overloading causing congested states with peripheral and

pulmonary edema is directly proportional to the electrolyte concentrations of the injections·

In patients with diminished renal functon, administration of VetOne OsmoSol–R 7·4

(Multiple Electrolyte Injection‚ Type 1‚ USP) may result in sodium or potassium retention·

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Adverse reactions may occur due to the solution or the technique of administration

including febrile response, infection at the site of injection or alergic reactions.

Prolonged intravenous infusion of this type of product may cause venous thrombosis

or phlebitis extending from the site of injection‚ extravasation, and hypervolemia·

If an adverse reaction does occur, discontinue the infusion and evaluate the patient,

institute appropriate therapeutic countermeasures, and save the remainder of the

fluid for examination if deemed necessary·

PRECAUTIONS

PRECAUTIONS SECTION

This is a single dose unit. It contains no preservatives. Use entire contents when

first opened·

Clinical evaluation and periodic laboratory determinations are necessary to monitor

changes in fluid balance, electrolyte concentrations, and acid base balance during

prolonged therapy or whenever the condition of the patient warrants such evaluation.

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) should be used

with caution. Excess administration may result in metabolic alkalosis·

Caution must be exercised in the administration of VetOne OsmoSol–R 7·4 (Multiple

Electrolyte Injection‚ Type 1‚ USP) to patients receiving corticosteroids or corticotropin·

Do not administer unless soution is clear and both seal and container are intact·

Solution must be warmed to body temperature prior to administration and administered

at a slow rate. Use solution promptly following initial entry·

Reactions which may occur because of the solution or the technique of administration‚

include febrile response, infection at the Site of injection, extravasation, and hypervolemia·

If an adverse reaction does occur, discontinue the infusion and evaluate the patient,

institute appropriate therapeutic countermeasures, and save the remainder of the fluid

for examination if deemed necessary·

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

To be used as directed by a licensed veterinarian. The dosage of the VetOne

OsmoSol–R 7·4 (Multiple Electrolyte Injection, Type 1, USP) is dependent upon

the age, weight and clinical conditions of the patient as well as laboratory

determinations. Parenteral drug products should be inspected visually for

particulate matter and discoloration prior to administration.

For use in one patient on one occasion only. Discard any unused portion.

Care should be taken with administration technique to avoid administration

site reactions and infection·

Additives may be incompatible. Complete information is not available. Those

additives known to be incompatible should not be used. Consult with Pharmacist,

if available. If, in the informed judgement of the veterinarian, it is deemed

advisable to introduce additives, use aseptic technique. Mix thoroughly when

additives have been introduced. Do not store solutions containing additives·

OVERDOSAGE

OVERDOSAGE SECTION

In an event of over-hydration or solute overload, re-evaluate the patient and institute

appropriate corrective measures. See Warnings, Precautions and Adverse Events·

PACKS SUPPLIED

SPL UNCLASSIFIED SECTION

VetOne OsmoSol–R 7·4 (Multiple Electrolyte Injection‚ Type 1‚ USP) in plastic container

is available as follows:

image descriptionimage description
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat.

It is recommended the product be stored at room temperature (86°F/30°C). Protect from

freezing·

DIRECTIONS FOR USE OF PLASTIC CONTAINER

SPL UNCLASSIFIED SECTION

To Open

Tear overwrap at slit and remove solution container. Some opacity of the plastic due to

moisture absorption during the sterilization process may be observed. This is normal

and does not affect the solution quality or safety. The opacity will diminish gradually.

Check for minute leaks by squeezing solution container firmly. If leaks are found,

discard solution as sterility may be impaired·

If supplemental medication is desired, follow directions below:

Preparation for Administration

1. Suspend container from eyelet support·

2. Remove plastic protector from inlet/outlet port at bottom of container.

3. Attach administration set.

To Add Medication

WARNING:Additives may be incompatible.

To add medication before solution administration

1. Prepare medication site.

2. Using syringe with 0.63mm to 0·80mm needle, puncture medication port and inject.

3. Mix solution and medication thoroughly. For high density medication such as potassium

chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration

1. Close the clamp on the administration set.

2. Prepare medication site.

3. Using syringe with 0.63mm to 0·80mm needle, puncture medication port and inject.

4. Remove container from IV pole and/or turn to an upright position.

5. Evacuate both ports by squeezing them while container is in the upright position.

6. Mix solution and medication thoroughly·

7. Return container to in use position and continue administration·

CAUTION

WARNINGS SECTION

FEDERAL LAW RESTRICTS THIS DRUG TO USE BY OR ON THE ORDER OF A LICENSED

VETERINARIAN.

INFORMATION FOR OWNERS/CAREGIVERS SECTION

Made in Australia

Manufactured by:

Sypharma Pty Ltd

27 Healey Road Dandenong

Victoria 3175 Australia

Distributed by: MWI

Boise, ID 83705

www.VetOne.net

Iss. 04/18

Vetone OsmoSol–R 7·4 (Multiple Electrolyte Injection, Type 1, USP) 1000ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

Vetone OsmoSol–R 7·4 (Multiple Electrolyte Injection, Type 1, USP) 5000ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130313985932052GTIN-13: 0313985932052
EAN-13: 0313985932052
GTIN-12: 313985932052
UPC-A: 313985932052
GTIN storage (14 digits): 00313985932052
Osmosol-R 7.4 Injection 5000ml.jpg

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
13985-932VETONE (OSMOSOL-R 7.4 SODIUM CHLORIDE,SODIUM GLUCONATE,SODIUM ACETATE,POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE) INJECTION, SOLUTION [MWI]2Unmatched20180830_1f24e055-b031-4439-bf61-ba79a93e53d3.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
13985-93213985-932-01, 13985-932-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 9 · 180 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5e74e26d-fe34-8784-e063-6394a90ae1942026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5ed79ba5-43a0-c323-e063-6394a90a46182026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5eda970a-6fe4-8af3-e063-6394a90a57622026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIX USA, INC.5edb1f1e-122d-f0da-e063-6394a90a4ccd2026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
BiologixCare Sterile Saline Wound WashSODIUM CHLORIDEBIOLOGIXUSA, INC.5ede6a14-cc47-8423-e063-6294a90a58c52026-10-29WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDECardinal Health 107, LLC97007188-43fe-416c-a87b-6ccc4d9ae2ec2026-10-28Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
QUALITY CHOICE SALINESODIUM CHLORIDEQUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION)f51491d8-12ad-4b1b-a171-c621bfdcc3412026-10-28WarningsName fallback
generic name: SODIUM CHLORIDE
Normal SaltSODIUM CHLORIDEGRAXCELL PHARMACEUTICAL, LLCf3f09817-8a38-4aa1-956b-69d9cf6950742026-10-26WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDECODAN US CORPORATIONaa06e286-75c6-4d7a-959f-6008d38aa6e52026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDENextgen Pharmaceuticals LLC28f79c75-82d2-4912-81fc-a723b5ccf4c12026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDESOLA Pharmaceuticals, LLC4d0bfd28-460a-48ba-bd17-cf75e56d62f42026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDELABORATORIOS GRIFOLS SAeb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf2026-10-08Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Personal CARE Saline NasalSODIUM CHLORIDEDelta Brands Inc.5ccaf7a1-6891-eac4-e063-6294a90a829f2026-10-02WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium Chloride Hypertonicity OphthalmicSODIUM CHLORIDERugby Laboratories7546770d-bc12-44b8-9fe0-fc3f5e1d12d12026-09-24WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium Chlorode Hypertonicity Ophthalmic SolutionSODIUM CHLORIDERugby Laboratories822d25c0-71b3-421d-b702-4cded0c4ca322026-09-23WarningsName fallback
generic name: SODIUM CHLORIDE
BURBLESODIUM CHLORIDELETS BURBLE, INC.17f48d4f-907c-3829-e063-6394a90ab2022026-09-22WarningsName fallback
generic name: SODIUM CHLORIDE
Nacl 0.9% Normal Saline SolutionSODIUM CHLORIDECHI FUNG TECHNOLOGY COMPANY5a53c4c8-c9de-700c-e063-6394a90a3ab52026-08-31WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDEYYBA CORP597f3347-647c-3545-e063-6294a90abab22026-08-20WarningsName fallback
generic name: SODIUM CHLORIDE
Sodium ChlorideSODIUM CHLORIDEFresenius Kabi USA, LLC2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e882026-08-20Warnings, Adverse reactionsName fallback
generic name: SODIUM CHLORIDE
Hypertonic SalineSODIUM CHLORIDENAVEH PHARMA (1996) LTD167c7a9c-1228-4fb2-a89c-d3e1483863232026-07-30WarningsName fallback
generic name: SODIUM CHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.